In the press: North East Times speaks to three promising spin-outs
North East Times magazine’s September issue shines a light on three of Northern Accelerator’s latest spin-out companies from Newcastle and Durham Universities. Skin Life Analytics, ESP Diagnostics and Respiratone were supported by Northern Accelerator to spin-out of the region’s universities recently, utilising our Executives into Business programme and other support to ensure the best chance […]
AMLo Biosciences raises £2.45m to further develop early stage skin cancer test
AMLo Biosciences Ltd (AMLo), an innovative medical device company spun out of Newcastle University specialising in the early detection of skin cancers, has secured significant further investment totalling £2.45m. At present all early stage melanomas are treated in a similar way, sometimes involving invasive surveillance diagnostics designed to identify the few high-risk melanomas at the […]
In the press: North East Times features inspiring spin-out journey
In April’s North East Times magazine, Editor Steven Hugill caught up with Billy Webber, CEO of XR Therapeutics. Billy leads the Newcastle University spin-out, having been brought on board as CEO through Northern Accelerator’s Executives into Business programme. Read the full feature to find out more about how XR Therapeutics is bringing its next generation […]
Newcastle biotech spin-out raises £1.75m to accelerate technology launch
Biotech technology disrupter CellulaREvolution, which aims to revolutionise the way cells are grown, has raised £1.75 million from a group of notable investors in a round led by Happiness Capital, including Allusion One, the first investment arm of Allusion. The investment will be used to accelerate research & development and strengthen their commercial team as […]
Northern Accelerator’s first spin-out secures further £425k investment
Atelerix was spun out of Newcastle University in 2017 by three co-founders, Professor Che Connon, Dr Steve Swioklo and Dr Mick McLean. The conventional freezing and thawing of cells and tissues through cryogenics can be hugely damaging, and these cells often die or change their function in the process. To tackle this problem, Atelerix has […]
Newcastle spin-out creating more and better jobs
Newcastle University spin-out GlycoScoreDX is recruiting a Research Technician based in Newcastle, as the company continues to develop and expand, creating high quality jobs in the North East. GlycoScoreDx aims to transform the future of prostate cancer diagnosis, through the spin-out company founded upon research by Dr Jennifer Munkley and her research group. Find out […]
Newcastle University spin-out GlycoScoreDX raises £1m seed funding
North East-based diagnostics company and Newcastle University spin-out, GlycoScoreDx, has secured £630,000 in equity funding alongside an additional £360,000 in grant funding to support business establishment and early development of its proprietary Prostate Cancer test. The GlycoScore Prostate Cancer test is a simple, reliable blood test which can be used to accurately diagnose and risk-assess […]
CellulaREvolution raises £1m to further accelerate the development of lab grown cells
Technology disrupter CellulaREvolution, which aims to revolutionise the way cells are grown in labs, has raised £1million from a set of strategic investors including CPT Capital, Stephan Schmidt, Orange Light Ventures, and funds managed by Northstar Ventures, the North East Innovation Fund supported by the European Regional Development Fund and the newly launched Northern Accelerator […]
3D Bio-Tissues moves into specialist lab facility at The Biosphere on Newcastle Helix
Another Northern Accelerator spin-out from Newcastle University is making its home at The Biosphere on Newcastle Helix, joining a growing cluster of life science businesses. 3D Bio-Tissues aims to tackle donor shortages and speed up life-changing transplants worldwide, specialising in creating ‘bio-equivalent’ structural tissues. Dr Che Connon, co-founder and CEO of 3D Bio-Tissues said: “The […]
Newcastle University spin-out joins The Biosphere at Newcastle Helix
Newcastle University spin-out, AMLo Biosciences, has moved to The Biosphere, a specialist lab facility on Newcastle Helix. The ground-breaking cancer diagnostics firm, formed in 2017, looks to save up to 2,000 lives each year with their prognostic test for early-stage skin cancer. The company’s first product (AMBLor) will go to market in 2021, launching in […]
